Ironwood Pharmaceuticals Inc financial data

Symbol
IRWD on Nasdaq
Location
100 Summer Street, Suite 2300, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 193 % +89.3%
Return On Equity 2.51 %
Return On Assets -2.24 % -211%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 162M shares +1.69%
Common Stock, Shares, Outstanding 162M shares +1.69%
Entity Public Float 917M USD -37.4%
Common Stock, Value, Issued 162K USD +1.25%
Weighted Average Number of Shares Outstanding, Basic 162M shares +1.7%
Weighted Average Number of Shares Outstanding, Diluted 177M shares +11.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 309M USD -23%
Research and Development Expense 106M USD -15.1%
Costs and Expenses 235M USD -18%
Operating Income (Loss) 73.3M USD -35.4%
Nonoperating Income (Expense) -30.4M USD -10.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 42.9M USD -50.2%
Income Tax Expense (Benefit) 50.8M USD -35.7%
Net Income (Loss) Attributable to Parent -7.89M USD -186%
Earnings Per Share, Basic 0 USD/shares -200%
Earnings Per Share, Diluted 0 USD/shares -250%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 92.9M USD -12%
Accounts Receivable, after Allowance for Credit Loss, Current 86.2M USD +48.3%
Assets, Current 192M USD +7.62%
Deferred Income Tax Assets, Net 129M USD -32.9%
Property, Plant and Equipment, Net 3.93M USD -22.5%
Operating Lease, Right-of-Use Asset 10.2M USD -13.7%
Other Assets, Noncurrent 5.15M USD +21%
Assets 343M USD -13.3%
Accounts Payable, Current 1.39M USD -57%
Employee-related Liabilities, Current 8.13M USD -36.9%
Contract with Customer, Liability, Current 978K USD -53.4%
Liabilities, Current 233M USD +411%
Operating Lease, Liability, Noncurrent 11.1M USD -17.4%
Other Liabilities, Noncurrent 22.5M USD -35.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.03M USD -331%
Retained Earnings (Accumulated Deficit) -1.71B USD -0.46%
Stockholders' Equity Attributable to Parent -308M USD +4.22%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -308M USD +4.22%
Liabilities and Equity 343M USD -13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 20M USD -55.6%
Net Cash Provided by (Used in) Financing Activities -15.6M USD -491%
Net Cash Provided by (Used in) Investing Activities -31K USD +54.4%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 162M shares +1.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19.9M USD -32.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 92.9M USD -12%
Deferred Tax Assets, Valuation Allowance 106M USD +24.1%
Deferred Tax Assets, Gross 254M USD -15.7%
Operating Lease, Liability 14.3M USD -13.7%
Depreciation 479K USD -6.63%
Payments to Acquire Property, Plant, and Equipment 31K USD -54.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.44M USD -207%
Lessee, Operating Lease, Liability, to be Paid 16.5M USD -16.1%
Property, Plant and Equipment, Gross 12.9M USD -11.2%
Operating Lease, Liability, Current 3.22M USD +2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.32M USD +2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.25M USD +1.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.12M USD -29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.38M USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 147M USD +39.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 75M shares 0%
Unrecognized Tax Benefits 11.6M USD -88.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.45M USD +1.98%
Operating Lease, Payments 788K USD +1.94%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 22.7M USD -32.3%
Interest Expense 27.3M USD +303%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%